Learning Objectives:

  • Describe current and emerging biotherapies and targeted treatments used in pediatric oncology
  • Recognize the early signs and symptoms of malignancies that may benefit from advanced therapies
  • Understand the pediatrician’s role in long-term surveillance and shared care for patients receiving these treatments -
  • Identify when and how to refer pediatric patients for specialized oncology evaluation or clinical trials
Session date: 
09/10/2025 - 12:00pm to 1:00pm EDT
Location: 
https://childrensnational.zoom.us/webinar/register/WN_-0G9uOUmQNSChmff0ncA-Q#/registration
United States
  • 1.00 AMA PRA Category 1 Credit
    Children’s National Hospital designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Participation
    Successful completion of this continuing education activity.
Please login or register to take this course.